Oncotelic chief business officer gives AI drug discovery keynote at Drug Discovery Strategic Summit
OTLC•Oncotelic Therapeutics Chief Business Officer Saran Saund will deliver a keynote on AI-enabled drug discovery on October 22, 2026, at The Westin San Francisco Airport in Millbrae, California.
1. Keynote details
Saund's presentation is scheduled for 9:00 to 9:25 a.m. Pacific Time at the 22nd Drug Discovery Strategic Summit. He will discuss partition and aggregation in AI-enabled discovery, linking the approach to PDAOAI technology and planned genetic discovery expansion.
